Drugs Information: Pegademase

Basic Information

ID DDInter1402
Drug Type biotech
Molecular Formula C1821H2834N484O552S14
Molecular Weight -
Description Pegademase is a modified form of bovine adenosine deaminase used to treat adenosine deaminase deficiency, a condition which leads to the formation of adenosine metabolites which are cytotoxic to lymphocytes.
ATC Classification L03AX04
IUPAC Name None
InChI None
InChI Key None
Canonical SMILES None
Useful Links DrugBank

Interactions with Pegademase

Severity level ID Name Mechanism Detail